positive
Recently
Medline set for largest IPO of 2025 ahead of Nasdaq debut
Medline’s $6.26B Nasdaq IPO marks 2025’s largest global listing, with strong demand lifting pricing above expectations.
Medline, a U.S. medical supply company backed by Blackstone, Carlyle and Hellman & Friedman, is poised to debut on the Nasdaq after raising about $6.26 billion in the biggest global IPO of 2025. The company sold 216 million shares at $29 each, above initial guidance, highlighting resilient U.S. IPO activity. Medline supplies surgical kits and protective gear worldwide and plans to begin trading under the ticker “MDLN.”